z-logo
Premium
The Differential Regulation of CART Gene Expression in a Pituitary Cell Line and Primary Cell Cultures of Ovine Pars Tuberalis Cells
Author(s) -
Barrett P.,
Morris M. A.,
Moar K. M.,
Mercer J. G.,
Davidson J. A.,
Findlay P. A.,
Adam C. L.,
Morgan P. J.
Publication year - 2001
Publication title -
journal of neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.062
H-Index - 116
eISSN - 1365-2826
pISSN - 0953-8194
DOI - 10.1046/j.1365-2826.2001.00634.x
Subject(s) - pars tuberalis , signal transduction , cart , biology , gene expression , regulation of gene expression , microbiology and biotechnology , cell culture , protein kinase c , gene , pituitary gland , endocrinology , genetics , hormone , mechanical engineering , engineering
The cocaine‐amphetamine regulated transcript (CART) encodes for a protein which has an important role in the regulation of appetite and body weight. To date, no details of the molecular events and signal transduction pathways which regulate this gene are available. We report the identification of CART gene expression in the GH3 pituitary cell line. We have used activators of the cAMP or protein kinase C (PKC) signal transduction pathways to show that, in GH3 cells, CART is transcriptionally up‐regulated by activators of the cAMP signal transduction pathway. We also identify CART gene expression in ovine pars tuberalis (PT) tissue and primary cell cultures. In PT cells in contrast to GH3 cells, CART gene expression is upregulated by activators of the PKC signal transduction pathway. Cultured cells have provided a valuable resource for the detailed analysis of specific regulatory mechanisms underlying transcriptional or translational regulation of genes, signal transduction events and many other cellular processes. GH3 and PT cells may therefore provide a resource for the further detailed molecular analysis of the events regulating CART gene expression and processing.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here